跳至主要内容
临床试验/NCT00806403
NCT00806403已完成4 期

Very Early Initiation of Treatment With Thrombolysis and Low Molecular Weight Heparin, Versus Abciximab and Low Molecular Weight Heparin Followed by Percutaneous Coronary Intervention, for Acute ST-Elevation Myocardial Infarction

Sahlgrenska University Hospital, Sweden5 个研究点 分布在 1 个国家目标入组 205 人开始时间: 2001年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
205
试验地点
5
主要终点
Number of Patients With ST-segment Elevation Resolution Equal or More Than 50%

研究概览

简要总结

The main objective is to compare a fibrinolytic strategy with an interventional strategy initiated as early as possible, preferably in the pre-hospital phase, with respect to resolution of ST-segment elevation at 120 minutes after inclusion and Thrombolysis In Myocardial Infarction (TIMI) flow grade evaluated at a mandated coronary angiography 5 to 7 days after inclusion.

详细描述

Patients in the fibrinolytic group received an intravenous injection of 30 mg enoxaparin followed by subcutaneous injections of 1 mg/kg body weight every 12 hours during hospital stay.

Patients in the invasive group were given an intravenous injection of enoxaparin of (0.75 mg/kg body weight) and abciximab as a intravenous bolus (0.25 mg/kg body weight) followed by a 12 hour infusion (10 microg/minute).

Secondary outcome measures were death, myocardial infarction and stroke alone or as a composite at 30 days.

Data on use of health care resources, loss of production and health-related quality of life were collected during one year. Cost-effectiveness was determined by comparing costs and quality-adjusted survival.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients presenting within 6 h after onset of chest pain lasting for more than 30 min and with significant ST-segment elevation on ECG.

排除标准

  • BP >180/110
  • Known bleeding disorder
  • Cardiogenic shock
  • CPR>10 min
  • Ongoing anticoagulant therapy
  • Renal insufficiency
  • Weight >120 kg

研究组 & 干预措施

thrombolysis

Active Comparator

干预措施: reteplase 10+10 U (Drug)

invasive

Active Comparator

干预措施: primary PCI (Procedure)

结局指标

主要结局

Number of Patients With ST-segment Elevation Resolution Equal or More Than 50%

时间窗: 120 minutes after inclusion

ST-segment elevation resolution was measured in the lead with most prominent ST elevation at time of inclusion

Number of Patients With Thrombolysis In Myocardial Infarction (TIMI) Flow Grade 3

时间窗: 5-7 days after inclusion

Thrombolysis In Myocardial Infarction (TIMI) flow grade in the infarct related artery 5-7 days after inclusion.

次要结局

  • Death(30 days)
  • Reinfarction(30 days)
  • Stroke(30 days)

研究者

发起方
Sahlgrenska University Hospital, Sweden
申办方类型
Other

研究点 (5)

Loading locations...

相似试验